Brevia Health has developed the first UK parliamentary tracker of diseases.
The Disease Profile Tracker examines parliamentary interest in the key diseases affecting the UK population including Alzheimer’s, cancer, diabetes and heart disease.
Our Tracker offers unique insight into which diseases are being discussed and the activities that can trigger interest from Parliamentarians in the House of Commons and the House of Lords.
Our dataset begins in December 2019, at the start of the last Conservative Government, and runs to the present day.
Each month, we can see how diseases are examined by the UK Parliament, emerging trends and the advocacy strategies that work.
Our comprehensive dataset, sourced from official parliamentary records, commenced in December 2019, at the start of the last Conservative Government, and runs to the present day.
We use data from the ONS to identify the top 20 diseases in England and Wales. Each month, our team of health consultants update the tracker to identify changes in parliamentary activity.
Our Tracker enables us to pinpoint factors that drive momentum in parliament, helping us to identify effective advocacy strategies.
The Tracker enables us to provide unique insight on how diseases are examined by UK Parliamentarians, identify emerging trends and design effective advocacy strategies.
As we enter the second half of 2025, Brevia Health has collected and analysed data on parliamentary discussions surrounding the leading diseases in the UK.
In June 2025, dementia and Alzheimer’s disease took centre stage with a surge in parliamentary interest aligned with national awareness campaigns.
February 2025 was a month marked by World Cancer Day, which sparked a significant increase in discussions around cancer awareness and treatment in the UK
Brevia Health’s Disease Profile Tracker offers unique insights into which diseases are being discussed by UK Parliamentarians and advocacy initiatives that can trigger interest. This
Key highlights in 2024 A breakdown of prostate cancer interest in the UK Parliament Prostate cancer is the most common cancer for men in the
